Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mogensen

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Journal of Medicinal Chemistry|May 28, 2004
Arylcyanoguanidines as activators of Kir6.2/SUR1K ATP channels and inhibitors of insulin releaseTina M Tagmose, Søren C Schou, John P Mogensen, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2002
Design and synthesis of novel PPARalpha/gamma/delta triple activators using a known PPARalpha/gamma dual activator as structural templateJohn P Mogensen, Lone Jeppesen, Paul S Bury, et al.
Journal of Medicinal Chemistry|March 9, 2007
Identification and synthesis of a novel selective partial PPARdelta agonist with full efficacy on lipid metabolism in vitro and in vivoPer Sauerberg, Grith S Olsen, Lone Jeppesen, et al.
Journal of Medicinal Chemistry|September 6, 2002
6-Chloro-3-alkylamino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide derivatives potently and selectively activate ATP sensitive potassium channels of pancreatic beta-cellsFlemming E Nielsen, Thora B Bodvarsdottir, Anne Worsaae, et al.
Journal of Medicinal Chemistry|February 8, 2002
Novel tricyclic-alpha-alkyloxyphenylpropionic acids: dual PPARalpha/gamma agonists with hypolipidemic and antidiabetic activityPer Sauerberg, Ingrid Pettersson, Lone Jeppesen, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Journal of Medicinal Chemistry|May 28, 2004
Arylcyanoguanidines as activators of Kir6.2/SUR1K ATP channels and inhibitors of insulin releaseTina M Tagmose, Søren C Schou, John P Mogensen, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2002
Design and synthesis of novel PPARalpha/gamma/delta triple activators using a known PPARalpha/gamma dual activator as structural templateJohn P Mogensen, Lone Jeppesen, Paul S Bury, et al.
Journal of Medicinal Chemistry|March 9, 2007
Identification and synthesis of a novel selective partial PPARdelta agonist with full efficacy on lipid metabolism in vitro and in vivoPer Sauerberg, Grith S Olsen, Lone Jeppesen, et al.
Journal of Medicinal Chemistry|September 6, 2002
6-Chloro-3-alkylamino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide derivatives potently and selectively activate ATP sensitive potassium channels of pancreatic beta-cellsFlemming E Nielsen, Thora B Bodvarsdottir, Anne Worsaae, et al.
Journal of Medicinal Chemistry|February 8, 2002
Novel tricyclic-alpha-alkyloxyphenylpropionic acids: dual PPARalpha/gamma agonists with hypolipidemic and antidiabetic activityPer Sauerberg, Ingrid Pettersson, Lone Jeppesen, et al.
Pageof 8